---
category: corporate-action
circular_id: fee1cee03f7efb46
date: '2026-01-21'
description: DR Lalchandani Labs Limited has announced a 1:1 rights issue of equity
  shares at par value of Rs. 10 per share, with record date on January 27, 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2B42EAF5-7BDD-4E72-9316-67E1CF24E2B3}&noticeno=20260121-50&dt=01/21/2026&icount=50&totcount=57&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard rights issue announcement affecting existing shareholders
  with 1:1 entitlement ratio at par value
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260121-50&attachedId=
processing:
  attempts: 1
  content_hash: dfd23c6faabaabe9
  processed_at: '2026-01-21T15:43:40.014552'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-21T14:19:03+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2B42EAF5-7BDD-4E72-9316-67E1CF24E2B3}&noticeno=20260121-50&dt=01/21/2026&icount=50&totcount=57&flag=0
severity: medium
source: bse
stocks:
- DRLABS
tags:
- rights-issue
- corporate-action
- equity-shares
- record-date
- ex-rights
title: Rights Issue of DR Lalchandani Labs Limited - 1:1 at Par
---

## Summary

DR Lalchandani Labs Limited (Scrip Code: 541299) has fixed the record date for a rights issue of equity shares. The company will issue 1 equity share of Rs. 10 each for every 1 equity share held by shareholders as on the record date. Trading will be on ex-rights basis from January 27, 2026.

## Key Points

- Rights ratio: 1:1 (one new share for every one share held)
- Face value: Rs. 10 per share
- Issue price: Rs. 10 per share (at par)
- Entire issue price payable on application
- Scrip code: 541299
- Settlement: DR-806/2025-2026
- Segment: Dematerialised Securities - Rolling Settlement

## Corporate Action Details

This is a rights issue where existing shareholders will be entitled to subscribe to one new equity share for every one share held on the record date. The shares are being offered at par value with no premium.

## Compliance Requirements

- Trading members must execute transactions on ex-rights basis from the specified date
- All trades from January 27, 2026 onwards will be without rights entitlement
- Trading members are required to note and implement this change

## Important Dates

- **Record Date**: January 27, 2026
- **Ex-Rights Date**: January 27, 2026
- **Notice Date**: January 21, 2026
- **Settlement Number**: DR-806/2025-2026

## Impact Assessment

**Shareholder Impact**: Existing shareholders will have the opportunity to maintain their proportional ownership by subscribing to the rights issue. The 1:1 ratio is dilutive for non-participating shareholders.

**Trading Impact**: Shares will trade ex-rights from January 27, 2026, which may result in price adjustment to reflect the rights entitlement separation.

**Payment Terms**: Full payment of Rs. 10 per share is required on application, with no installment option available.